AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 27 filers reported holding AVALO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,250,000 | $444,000 | 0.07% |
| Nantahala Capital Management | 556,202 | $197,563 | 0.02% |
| Virtu Financial LLC | 32,593 | $12 | 0.00% |
| First Horizon Advisors, Inc. | 276 | $98 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,127 | $1,465 | 0.00% |
| WELLS FARGO & COMPANY/MN | 160 | $57 | 0.00% |
| NORTHERN TRUST CORP | 10,836 | $3,849 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,919 | $680 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 62 | $22 | 0.00% |